Pharmacy Responds to Allegations of Profit-Making
On 21 March 2024, Federfarma responded to an article revealed by Corriere della Sera titled "Pharmacy-clinic that actually earns cash" and a Dataroom column on TG La7. The Federfarma representatives, Marco Cossolo, addressed the content material of the article and supplied explanations to make clear misunderstandings.
The article in query highlighted the earnings generated by pharmacies, particularly mentioning the pricing of anti-cancer medication. Federfarma emphasised that pharmacies obtain a set quantity for distributing anti-cancer medication on behalf of public our bodies and clarified that the talked about determine of 200 euros per field was inaccurate.
Furthermore, Federfarma pressured the significance of pharmacies as multi-functional neighborhood well being facilities, appearing as a bridge between hospitals and communities. They highlighted the function of pharmacies in offering important well being companies and debunked any misconceptions relating to the DDL Simplification provisions.
The response additionally addressed the growth of companies supplied by pharmacies, particularly through the pandemic. Federfarma highlighted the essential function pharmacies play in delivering well being companies, together with vaccinations and diagnostic checks.
In conclusion, Federfarma reiterated its dedication to transparency and correct data for the general public. They expressed their willingness to interact in additional discussions on the subject to make sure readability and understanding.
For extra updates on the medical discipline, observe us on our social media channels or subscribe to our publication. Stay knowledgeable and linked with the newest developments in healthcare.
Tags: Pharmacy Services, Federfarma, Marco Cossolo